African drugmaker in advanced talks to manufacture mpox vaccines

African drugmaker Aspen Pharmacare is in advanced talks with partners to manufacture mpox vaccines at its facilities, Chief Executive Officer Stephen Saad told Reuters on Tuesday.

"We are speaking to people, we have the capabilities, we can do it," he said in an interview.

Recommended For You

Death toll in UAE rises to 7; drone incident near DXB temporarily disrupts flights

Death toll in UAE at 7; injuries at 145 since February 28, says Ministry

India’s strong economy, energy strategy buffer oil shock impact 

UAE air defences engage 9 ballistic missiles, 33 UAVs from Iran on March 14

Bangladesh clinch ODI series with 11-run win over Pakistan

 

The United Nations Children's Fund (UNICEF) had earlier issued an emergency tender to secure mpox vaccines for crisis-hit countries in collaboration with the Gavi vaccine alliance, Africa CDC and the World Health Organization, the organisations said in a joint statement.

Depending on the production capacity of manufacturers, agreements for up to 12 million doses through 2025 can be made, according to the statement

ALSO READ:

Jordanian health ministry records mpox case for expat

Pakistan: Peshawar emerges as 'epicentre' of mpox as tally reaches five

Mpox patients lack medicine and food in east DR Congo hospital

Mpox: UAE sends vaccines to 5 countries to combat outbreak of virus